Fierce Pharma Week - Day 1 Expectations

A quick chat with Medisafe's Ryan Janvion, Stacey Wasserman and Cathy Zaremba on what to expect at Fierce Pharma Week 2025. Industry leaders discuss how hyper-personalization sets true patient engagement apart from the buzzwords that saturate the pharmaceutical industry.

• Excitement about sharing Medisafe's new updates with conference attendees
• The significance of behavioral intervention technology in creating effective patient engagement
• How direct-to-consumer experience enables hyper-personalization in healthcare
• Patient engagement becoming a popular concept but with varying levels of implementation
• The importance of building tools that support patients throughout their treatment journey
• 13 years of experience connecting with 13 million patients has created deep expertise

PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.

Episode Transcript

Speaker 1 (00:00):
Good morning.
I'm here with Stacey Wasserman.
Stacey, how you doing?
I'm doing well.
We're excited for a goodconference.
What are you looking forward tomost about this conference
coming up?

Speaker 2 (00:09):
Well, of course, great to see your friends,
colleagues, clients, but I'malso excited to tell people
about what's going on atMedisave.

Speaker 1 (00:19):
It's been a lot.
A lot of this changed over thelast month, or last year, I
should say.

Speaker 2 (00:23):
A lot of new stuff, a lot of new things to talk about
.

Speaker 1 (00:26):
Yeah, and this is probably the first time where
there's thousands of people here, so they combined it all into
one conference this year and alot of people probably the
biggest floor I've seen comingto conferences.
So a lot of people are going tobe stopping by the booth and
we're excited to tell them allthe new updates that Medisafe
has been having when it comes topatient engagement and patient
adherence.
All right, we are at FiercePharma Week.

(00:47):
My name is Ryan Jambion.
I am here with Kathy Zarembaand we are excited to kick off
Fierce Pharma Week 2025, talkinga little bit about patient
engagement, behavioralintervention technology.
Kathy, what are you lookingforward to most about the
conference coming up?

Speaker 2 (01:00):
Really looking forward to seeing colleagues I
haven't seen in a while andhearing what excites them about
patient engagement and reallylearning how they would define
behavioral interventiontechnology.
What does that mean to them?

Speaker 1 (01:12):
Huh, what does that mean to you actually?

Speaker 2 (01:15):
Well, actually it is what sets us apart.
I really believe that is whatgives us our
hyper-personalization.
That delivers patientengagement that matters, that
really delivers.
And we're really the only onesthat can do that because we have
the direct-to-consumerexperience.

Speaker 1 (01:29):
It's a trend that's happening a lot in pharma, not
only from a pharma marketingperspective.
Everyone's trying to figure outhow we can get closer to the
patient.
Ultimately, patient engagementhas become a huge buzzword right
, everybody's trying to getinvolved with patient engagement
and people can sound a lot veryyou know the same, it seems
like.
So we're excited to educatepeople on how we've been doing
this from the get go right,starting with patients and

(01:51):
giving them tools to bettersupport themselves across their
treatment journey.
So it should be a goodconference.
I'm looking forward to it.

Speaker 2 (01:57):
Me too.
We go deep in our experience.
13 years, 13 million patients,it's awesome.